Blue Owl Capital (NYSE:OWL) Given New $24.00 Price Target at Oppenheimer

Blue Owl Capital (NYSE:OWL) had its price target lifted by Oppenheimer from $21.00 to $24.00 in a report issued on Wednesday, Benzinga reports. They currently have an outperform rating on the stock.

Several other research analysts have also issued reports on the stock. UBS Group decreased their price target on shares of Blue Owl Capital from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Wednesday, July 10th. Piper Sandler raised their target price on shares of Blue Owl Capital from $20.00 to $23.00 and gave the company an “overweight” rating in a research note on Wednesday, October 9th. Evercore ISI boosted their price target on Blue Owl Capital from $21.00 to $22.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft cut their price target on Blue Owl Capital from $21.00 to $20.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Finally, JMP Securities lifted their price objective on Blue Owl Capital from $24.00 to $25.00 and gave the company a “market outperform” rating in a research note on Wednesday, October 9th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $21.15.

Blue Owl Capital Stock Performance

Blue Owl Capital stock opened at $22.35 on Wednesday. Blue Owl Capital has a fifty-two week low of $12.11 and a fifty-two week high of $22.64. The stock’s 50 day simple moving average is $18.46 and its two-hundred day simple moving average is $18.33. The stock has a market cap of $31.93 billion, a price-to-earnings ratio of 186.25, a PEG ratio of 1.29 and a beta of 1.18.

Blue Owl Capital (NYSE:OWL) last released its quarterly earnings results on Thursday, August 1st. The company reported $0.19 earnings per share for the quarter, meeting the consensus estimate of $0.19. The company had revenue of $549.85 million for the quarter, compared to analyst estimates of $507.22 million. Blue Owl Capital had a return on equity of 19.15% and a net margin of 4.64%. During the same period in the previous year, the company posted $0.16 earnings per share. On average, analysts predict that Blue Owl Capital will post 0.79 earnings per share for the current year.

Blue Owl Capital Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 21st were given a dividend of $0.18 per share. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $0.72 dividend on an annualized basis and a yield of 3.22%. Blue Owl Capital’s dividend payout ratio (DPR) is 600.00%.

Institutional Investors Weigh In On Blue Owl Capital

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Transcendent Capital Group LLC purchased a new position in shares of Blue Owl Capital in the 1st quarter worth $26,000. ORG Partners LLC bought a new position in Blue Owl Capital in the second quarter valued at about $32,000. ORG Wealth Partners LLC purchased a new position in Blue Owl Capital in the third quarter worth about $32,000. Family Firm Inc. bought a new stake in shares of Blue Owl Capital during the 2nd quarter valued at about $40,000. Finally, Rothschild Investment LLC purchased a new stake in shares of Blue Owl Capital during the 2nd quarter valued at about $45,000. Hedge funds and other institutional investors own 35.85% of the company’s stock.

Blue Owl Capital Company Profile

Blue Owl Capital Inc operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.